logo
More bad news for rat-infested cities: Climate change is making it worse

More bad news for rat-infested cities: Climate change is making it worse

CBC31-01-2025

Social Sharing
More rats: that's the latest indignity that climate change is dumping on major cities around the world, including in Canada's largest city, according to a new study from a group of global rodent and public health scientists.
Growing rat populations are correlated with rising temperatures driven by global warming in at least 11 major cities across the world, according to the study. The cities seeing rat increases include Toronto, famously rat-prone New York City, and many other major centres like Washington, San Francisco and Amsterdam.
The study's authors say it's a wake-up call for cities to move away from a whack-a-mole approach to dealing with rodent complaints.
"I think every large city should have a dedicated team that focuses on nothing but rodents and the issues with rodents," said Jonathan Richardson, lead author of the study and an urban ecologist at the University of Richmond in Virginia.
The study used data on public complaints and inspections about rats from 16 cities around the world. The 11 cities that saw significant increases in rats also experienced greater temperature increases over time, though that correlation doesn't prove the temperature caused the increase. Cities with more dense human populations and more urbanization also saw larger increases in rats.
The research comes at a time when rats have become a big issue in Toronto, which is seeing a large increase in rodent-related complaints after a brief decline during the COVID-19 pandemic. City officials are currently working on a new strategy to proactively deal with the rats.
"Even when you leave city hall or walk around city hall, you can see the burrows in the tree wells. I've walked along one of the streets and a giant rat ran past me in the middle of the day," said Alejandra Bravo, a Toronto city councillor who proposed the successful motion to build a rat strategy.
"I think people need to see action."
Toronto councillors push for rat reduction strategy
Why are rats thriving?
Rats are resilient and remarkably adaptable to different environments, says Alice Sinia, entomologist with pest control company Orkin Canada. It makes biological sense that warmer temperatures would be helping them out, for three big reasons.
The harsh winter acts as a sort of "nature's pest control," with the cold killing rats every year. Climate change has led to milder winters in Toronto, allowing greater numbers of rats to make it through the season.
Meanwhile, the warmer seasons have become longer, and that's when the rats breed and reproduce. Sinia says that could further boost their numbers.
And finally, climate disasters themselves could be bringing rats closer to people and buildings. Sinia used the example of the floods in Toronto in July last year, caused by a line of storms that dumped rain on the city in rapid succession in a matter of hours.
Studies suggest that Canada will see more extreme rain, with warmer air able to hold more moisture that it will dump in short, severe storms.
The flash floods last year caused nearly a billion dollars in insured damages, flooding basements, highways and transit stations across the city. But apart from the damage, floods also overwhelm the city's sewer system — which are teaming with rats that get displaced.
"Now instead of the underground sewers, they [the rats] will come to the surface and when that happens … they're going to start occupying other areas," Sinia said.
"They're going into people's homes, structures… and they're going to have an opportunity to reproduce very fast."
But none of this means people will just have to resign themselves to a rat-filled future, the experts said.
Keeping up the fight
Richardson, the study author, said that they key was a proactive rat strategy that addressed the root causes of infestations. That's similar to what the Toronto council is working on, according to Bravo. City staff will look at food disposal, managing construction sites, new approaches like birth control and other ways to manage the rat population on a larger scale.
Ultimately, Richardson says, cities need to put more money and resources into fighting rats, because simply tolerating them is not a good option.
"They carry at least 50 known zoonotic pathogens and parasites that can make residents sick in cities," he said. A zoonotic infection or disease is one that can transmit between animals and humans.
"They also have mental health impacts for residents where if you're living alongside rats regularly and see them in your daily life, you tend to have worse mental health outcomes and feel less secure in your environment.
"If we can reassess how much tolerance we have for rats in our everyday daily life as we're walking around, maybe that applies some pressure to the city governments and advocates for more resources to knock these populations back."

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

FDA approves Moderna's new lower-dose COVID-19 vaccine
FDA approves Moderna's new lower-dose COVID-19 vaccine

Winnipeg Free Press

time2 days ago

  • Winnipeg Free Press

FDA approves Moderna's new lower-dose COVID-19 vaccine

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it — not a replacement for the company's existing shot, but a second option. The new vaccine, mNexspike, is a step toward next-generation coronavirus vaccines. It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval 'adds an important new tool to help protect people at high risk of severe disease from COVID-19,' Stephane Bancel, Moderna's CEO, said in a statement Saturday. The Food and Drug Administration approved the new vaccine for use in all adults 65 and older, and for people age 12 to 64 who have a least one health condition that puts them at increased risk from the coronavirus. That's the same limit that the FDA set in licensing another COVID-19 vaccine option from competitor Novavax. Those restrictions are a departure from how the U.S. has handled COVID-19 vaccines until now, reflecting skepticism about vaccines from Health Secretary Robert F. Kennedy Jr. and other Trump officials. Moderna's existing vaccine doesn't face those limits and has long been used for anyone ages 6 months and older. The company said it expected to offer both options this fall. The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective — and more by some measures — than the original shot, the company said. The news came just days after the Trump administration canceled funding for Moderna to develop a vaccine against potential pandemic flu viruses, including the H5N1 bird flu, despite promising early study results. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

Trump administration cancels $766 million Moderna contract to fight pandemic flu
Trump administration cancels $766 million Moderna contract to fight pandemic flu

Winnipeg Free Press

time4 days ago

  • Winnipeg Free Press

Trump administration cancels $766 million Moderna contract to fight pandemic flu

The Trump administration has canceled $766 million awarded to drugmaker Moderna Inc. to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu. The company said it was notified Wednesday that the Health and Human Services Department had withdrawn funds awarded in July 2024 and in January to pay for development and purchase of its investigational vaccine. The funds were awarded through the Biomedical Advanced Research and Development Authority, or BARDA, a program that focuses on medical treatments for potential pandemics. The new vaccine, called mRNA-1018, used the same technology that allowed development and rollout of vaccines to fight Covid-19 in record time. Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding the safety of mRNA vaccines. The cancelation came as Moderna announced positive interim results from an early-stage trial of the vaccine that targeted H5 bird flu virus, tested in 300 healthy adults. 'While the termination of funding from HHS adds uncertainty, we are pleased by the robust immune response and safety profile observed in this interim analysis,' the company said in a statement. H5N1 bird flu viruses spilled from wild bird into cattle in the U.S. last year, infecting hundreds in several states. At least 70 people in the U.S. have been sickened by bird flu infections, mostly mild. One person died. Scientists fear that continued mutation of the virus could allow it to become more virulent or more easily spread in people, with the possibility that it could trigger a pandemic. Moderna received $176 million in July 2024 and $590 million in January. The January award would have supported a late-stage clinical trial that could have determined the vaccine's efficacy against pandemic viruses, including bird flu, a company spokesman said. — The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store